Clinical trial
Prospective multicentric evaluation of a bladder preservation strategy using a combination of neoadjuvant chemotherapy with intensified MVAC (M�thotrexate + vinblastine + adriamicine + Cisplatine) and optimal bladder transurethral resection in patients wi
The 5 years bladder preservation rate in patients with a localized infiltrative bladder treated with a double optimal transurethral bladder resection (TURB) combined with a neoadjuvant chemotherapy.
| Category | Value |
|---|---|
| Study start date | 2009-11-26 |